Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Atea Pharmaceuticals, Inc. (AVIR) has a Wall Street consensus price target of $6.88, based on estimates from 4 covering analysts. With the stock currently trading at $4.68, this represents a potential upside of +47.0%. The company has a market capitalization of $366M.
Analyst price targets range from a low of $6.88 to a high of $6.88, representing a 0% spread in expectations. The median target of $6.88 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, AVIR trades at a trailing P/E of -2.3x. Analysts expect EPS to grow +6.2% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how AVIR stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for AVIR is $6.88, representing 47.0% upside from the current price of $4.68. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
AVIR has a consensus rating of "Hold" based on 4 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $6.88 implies 47.0% upside from current levels.
AVIR's current price is $4.68 with a consensus target of $6.88 (47.0% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $6.88 for AVIR, while the most conservative target is $6.88. The consensus of $6.88 represents the median expectation. These targets typically reflect 12-month expectations.
AVIR is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 2 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AVIR stock forecast based on 4 Wall Street analysts shows a consensus price target of $6.88, with estimates ranging from $6.88 (bear case) to $6.88 (bull case). The median consensus rating is "Hold".
Wall Street analysts are very optimistic on AVIR, with a "Hold" consensus rating and $6.88 price target (47.0% upside). 1 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AVIR analyst price targets range from $6.88 to $6.88, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $6.88 consensus represents the middle ground.